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Copyright © 2010 JCBN Summary The bifidogenic effect of an infant formula supplemented with inulin and
fructooligosaccharides (4.0 g/l) was examined clinically and in vitro, and compared that of
mature breast milk. In a 28-day clinical study, fecal samples of 21 infants, divided into two
groups: one receiving the infant formula and the other breast milk, were microbiologically and
biochemically examined. In the in vitro investigation, microbiological and biochemical changes
in the infant formula and breast milk induced by the action of bifidobacteria isolated from
infant feces were examined. There were no significant differences in the fecal numbers of
lactobacilli, total aerobes, anaerobes or yeasts and fungi. In contrast, the bifidobacteria
numbers in the stools increased significantly during the study in the infants receiving the
supplemented formula. The comparative in vitro test showed that the bifidogenic effect was
similar for infant formula and breast milk in terms of the number of bifidobacteria. Consump-
tion of infant formula with added inulin and fructooligosaccharides stimulated the bifidogenic
effect, both clinically and in vitro. The in vitro test can quickly and objectively determine the
bifidogenic effect of infant formula and indicate their quality. However, a clinical test is
necessary to determine the acceptance and biological value of infant formula.
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Introduction
During birth and the days following, the sterile gastro-
intestinal tract of newborn infants becomes inoculated and
colonized with bacteria derived from the mother and the
environment [1, 2]. Different factors, including the type of
birth (vaginal or caesarean), the microflora of the mother’s
vagina and skin, hygiene during birth, the newborn’s environ-
ment, antibiotic regime and, above all, the type of diet,
influence the development of the gastrointestinal tract [3].
Human breast milk is the best dietary choice for newborn
infants, as it protects unweaned infants from allergies, infec-
tions and oxidative stress; breastfeeding also contributes to a
closer relationship between mother and child [4–7]. Milk
composition varies during the first days after birth and then
becomes suitable for the satisfaction of the dietary require-
ments of infants.
Breast milk is considered the gold standard against which
the quality of adapted formula milks is assessed. Formula
feeds, used by women who cannot breastfeed, should satisfy
all the nutritional requirements of the unweaned infant and
allow normal development. The intestinal microflora of
unweaned infants fed on formulas is more diverse than that
of infants fed on breast milk, and contains predominantly
bifidobacteria, and also significant quantities of Entero-Comparative Bifidogenic Effect of an Infant Formula
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bacteriaceae and gram-negative bacteria [8–10]. Bifido-
bacteria and lactobacilli are known to produce lactic, acetic
and other organic acids, which reduce the pH in the colon
and inhibit the growth of some pathogenic microorganisms
[11, 12].
The intestinal microflora of newborn infants can be
modified by the intake of dietary components, such as pro-
biotics or prebiotics. Prebiotics are indigestible compounds
found in foods which selectively stimulate the growth and
metabolic activity of the “good” bacterial species Bifido-
bacterium and Lactobacillus in the colon and improve
the health of the host [13, 14]. Oligosaccharides and other
components of breast milk are likely to be important sources
of the “prebiotic” effect. These indigestible oligosaccharides
in breast milk act on the microflora and, particularly,
contribute to the development of the predominating colonic
bifidobacterial microflora in newborn infants [15,  16].
Fructans in the concentration range of 2–10 g/l are considered
safe for use in the diets of children and unweaned infants
[16]. Inulin, an indigestible polysaccharide, is a natural
prebiotic which produces many desirable effects in humans,
including increased production of short-chain fatty acids,
stimulation of the growth and activity of bifidobacteria,
reduced serum cholesterol and triglycerides, and reduced
risks of colon cancer and colonic and intestinal infections
[17–20]. The examination of inulin-type prebiotics and their
applications are undergoing continual development due to
increasingly efficacious new molecular assessment methods
[21, 22].
The aim of this study was to investigate the influence of
an infant formula containing added inulin and fructooligo-
saccharides (FOS) on the gut microflora, as well as on the
growth and development of infants compared with infants
who were exclusively breastfed (considered the gold
standard for infant diets). The abilities of breast milk and
the infant formula to undergo bifidogenesis, a microbiological
indicator of the bifidogenic effect, were compared in a
clinical study and in an in vitro test. Infant growth and
development as well as the intestinal tolerance of the new-
born infants fed on the formula were followed. Finally, the
usefulness of the in vitro test as a rapid indicator of the
bifidigenic effect of formula feeds, compared to a clinical
study was evaluated.
Materials and Methods
Study population
Twenty one healthy, full-term, vaginally born infants with
a normal birth weight were enrolled in the study via the
Center for the Welfare of Infants, Children and Adolescents,
in Belgrade. All babies were younger than six months (age
between 5 and 16 weeks). The exclusion criteria were as
follows: antibiotic treatments, diarrhea, iron supplementa-
tion and intake of other prebiotics or probiotics. Mothers
of breast-fed infants were required to be in good health and
not to take antibiotics. The protocol and procedures for this
clinical study were fully approved by the Board of the
Center for the Welfare of Infants, Children and Adolescents.
Diet and experimental design
The 28-day study enrolled 21 infants of both sexes.
During the study period, infants were divided into two
groups: one group of infants (6 boys and 5 girls) was fully
formula-fed (FF), while the control group (7 boys and 3
girls) were exclusively breast milk-fed (BMF) by their
mothers. The FF group received an experimental full-term
infant formula designed for infants less than 6 months of age
and supplemented with inulin and FOS (4.0 g/l). The inulin
and FOS used in this study were produced from natural
chicory. The infant milk-based formula consisted of: lipids
(26.9), proteins (10.7) and carbohydrates (58.6) expressed as
g/100 g of powder, plus smaller amounts of vitamins (A, C,
D and E) and microelements. The main ingredients were
skimmed milk, lactalbumin, demineralized whey, lactose,
maltodextrin, glucose syrup, taurine, sunflower oils and
soybean lecithin.
The BMF and FF infants had the same schedule of visits
and specimen collection. Every day during the study, the
weight and length of the infants, number of feeds and
tolerance to the formula intake, and stool frequency and
consistency were recorded. The stool frequency was
reported as the number of stools in the previous 24 h period
and the consistency as soft, normal or hard.
Stools for bacteriological and biochemical analysis were
collected three times during the 28-day study: D0 (D-day),
before the observation period; D14, in the middle of the
supplementation period; and D28 at the end of the study.
After collection in sterile containers, the stools were
immediately placed at 4°C and transferred to the laboratory
for analysis.
Tolerance and well-being
The gastrointestinal symptoms and general health infor-
mation for each infant were evaluated daily by their parents
and care-givers from the care center. Slight gastrointestinal
disorders, decreased appetite, flatus and regurgitations were
recorded daily, and were considered as signs of discomfort,
but not as signs to suspend the study.
Laboratory methods
All fecal analyses, microbiological and biochemical, were
performed on fresh stools, immediately after transfer to the
laboratory.
Microbiological analysis of the fecal samples
Freshly collected fecal samples were well mixed withN.M. Lugonja et al.
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physiological saline (1 g in 99 ml) and serially diluted in the
same solution. Appropriate dilutions (1 ml) were transferred
to sterile Petri dishes and immediately pour-plated to isolate
and quantify bifidobacteria, lactobacilli, aerobes, anaerobes
and yeasts and fungi. Selective Bifidobacteria Medium with
Lactulose (BML) [23] was used for the isolation of
bifidobacteria. Lactobacilli were enumerated using Rogosa
agar [24]. Nutrient agar was employed for the enumeration
of total aerobic and facultative anaerobic bacteria. Sabuoraud-
dextrose agar was used for the enumeration of the total
yeasts and fungi. Nutrient agar with 0.5% glucose was used
for enumeration of the total anaerobic bacteria. Bifido-
bacteria and anaerobic bacteria were incubated under
anaerobic conditions (5% carbon dioxide (CO2)) in an
anaerostat (Heraeus, Hanau, Germany) at 37°C for 48 h.
Lactobacilli and aerobic bacteria were incubated aerobically
at 37°C for 48 h. Yeasts and fungi were incubated
aerobically at 28°C for 48 h. Bacterial, yeast and fungal
counts were expressed as CFU/g of feces.
Bacteria were identified using routine laboratory methods.
Bifidobacterium spp. were identified according their
morphology and the Rapid ID 32A® identification system
for anaerobes (BioMerieux, Marcy-l’Etoile, France).
Biochemical analysis of the fecal samples
The fecal pH was measured using a pH-meter, type PHM
26, with a combined glass electrode, type GK 2401C
(Radiometer). Total organic acids (TOA) were determined
by automatic potentiometric titration (titrator type TT 2,
Tacussel, France, combined glass electrode, type GK 2401C,
Radiometer) of 50 ml samples with a standard 0.1 M
NaOH solution. The results were calculated as lactic acid
equivalents and are expressed as g/100 ml. Stool water
content in feces, computed as % per g of feces, was deter-
mined using a hygrometer (Shimazu—moisture balance
MOC-120H). All chemicals employed in this study were
of analytical grade and purchased from Merck (Darmstadt,
Germany), Sigma (Steinheim, Germany) and Torlak
(Belgrade, Serbia).
Material for the isolation of bifidobacteria for the in vitro
test and the preparation of the inoculum
Material for the isolation of the accumulated mixed
culture of Bifidobacterium spp. was 1 g of a mixture of the
30 feces of healthy, vaginally and full-term born babies,
who were exclusively nursed and who did not consume
antibiotics. The feces were sampled three days after birth,
directly upon excretion. All samples were frozen immediately
at −20°C until the preparation of the inoculum.
Bifidobacteria were isolated on a solid selective BML.
The inoculum was prepared from the third 48 h subculture
on a BML agar slant, into 10 ml liquid BML, which was then
incubated for 48 h at 37°C in an anaerostat (Heraeus) in 5%
CO2. The total volume required was prepared by mixing
several individual inoculums in order to obtain a large
enough biomass for all the required seedings.
Substrate for the in vitro test
Experimental full-term infant formula milk supplemented
with inulin and FOS (4.0 g/l) was used as infant food
(100 ml ready meal was prepared from 14 g of powder
and 90 ml of water; designation IF). Mature breast milk
(designation MBM) was the reference substrate and it was
comprised of equal volumes of 20 breast milks obtained
from 20 healthy mothers who had delivered full-term infants
(the samples were obtained from 3 to 10 days postpartum).
Pancreatic digestion–digestion simulation [25]
Digestion was realized in 300 ml wide-necked Erlenmeyer
flasks containing 100 ml of substrate plus 50,000 USNF
units [26] each of amylase and protease and 4,000 USNF
units of lipase (pancreatin powder; A. Costantino & C.
Favria, Italy). The process was performed by immersion in a
water bath at 37°C for 2 h, with occasional shaking. Diges-
tion was halted by sterilization (121°C for 20 min), which
induced thermal deactivation of the enzymes. For one series
of experiments, two Erlenmeyer flasks with the same sub-
strates were prepared, one of which was used after inocula-
tion for the determination of the parameters at the beginning
of the test.
In vitro bifidogenesis
Sterile “digested” substrates were inoculated with 1.0 ml
of inoculum from the same accumulated mixed culture of
bifidobacteria. Bifidogenesis lasted 48 h at 37°C in an
anaerostat with 5% CO2.
Identification of the bifidobacterial isolates in vitro
From the BML medium, colonies were picked and
identified as a member of the genus Bifidobacterium by
typical morphology and RAPID ID 32A® test results. To
examine the morphology, a native preparation was prepared
from the substrate and observed with a light microscope
operating in the bright field (Laboval, Zeiss, Germany).
Determination of the total number of in vitro bifidobacteria
(TNB) [27]
Suitable dilutions of substrates and pure cultures of
bifidobacteria were prepared in physiological saline and
spread-plated onto BML agar. The BML agar plates were
incubated for 48 h at 37°C in a 5% CO2 atmosphere, after
which the isolated bifidobacteria colonies on the plates were
counted to obtain the TNB (expressed as colony-forming
units per ml (CFU/ml)).Comparative Bifidogenic Effect of an Infant Formula
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Biochemical analysis of the in vitro milk samples
The dry biomass (DBM; g/100 ml) [28] was determined
gravimetrically from 10 ml culture-inoculated substrate, by
centrifugation at 4,500 rpm for 10 min, triple water rinsing
and measurement using a hygrometer (Shimazu, Kyoto,
Japan). The pH and total organic acids were determined as
described before. The molar ratio of acetic and lactic acid
(MRAL) was determined by enzymatic tests in accordance
with the producer’s instructions (Randox, UK) [29,  30],
modified for these substrates (filtration through a 0.2 µm
pore size membrane and without alkaline hydrolysis).
Statistical analysis
All statistical analyses were realized using the statistical
software package SPSS for Windows V. 11.5. Values are
reported as means ± standard deviation (SD). Values of
p<0.05 were considered statistically significant. Parameters
(anthropometric, microbiological and biochemical) were
tested for normal distribution and compared using the t test.
Analysis of the influence of the type of feeding was per-
formed by multivariate analysis of variance with repeated
measurements. Internal Group Factor (within subject
factors—F1) and Factor of Differences between the Groups
(between subject factors—F1 group) were used to test for
significant differences between the study period and mode
of feeding.
Results
A clinical study and an in vitro artificial model simulating
gastrointestinal transit were used to compare the bifidogenic
effect of an infant formula with added inulin and FOS with
that of breast milk. The clinical study compared the effects
on healthy infants of feeding the supplemented infant
formula compared to breast milk. The in vitro test consisted
of successive incubation chambers containing either IF or
MBM, artificially digested and subsequently inoculated and
incubated with bifidobacteria.
In the clinical study, the study groups were comparable
with respect to clinical characteristics (Table 1). At the
beginning of the study, the ages of the infants were similar;
8.0 ± 2.6 and 9.3 ± 3.3 weeks for the FF and BMF groups,
respectively. The body weight and length of the infants in
both study groups increased at similar rates during the study
period and were within the normal framework for the
postnatal period. All infants exhibited normal growth during
the study.
Tolerance and well-being
In the study, all infants in each group liked the offered
milks. The intake of the bottle formula with added inulin
and FOS at 4.0 g/l was well tolerated by the infants: the
incidence of side effects did not differ among the feeding
Table 1. Clinical data in groups of the infants enrolled in the study (given as mean ± SD)
*The p value represents the significance level of the difference in the change between the groups during the study.
**Weight and length gain were calculated for the time period between the start and end of the study. Age at the beginning of the
study is given in weeks.
Type of feeding
Study group
p* Infant formula with added inulin 
and FOS (FF)
Breastfeeding (BMF)
Number of infants (M/F) 11 (6/5) 10 (7/3) 0.695
Postnatal age (weeks) 8.0 ± 2.6 9.3 ± 3.3 0.327
Weight (g)
D0 4124.55 ± 662.40 4838.0 ± 815.58 0.040
D28 4800.91 ± 675.76 5453.0 ± 809.73 0.059
Weight Gain 676.36 ± 294.11 615.0 ± 243.50 0.611
Length (cm)
D0 54.36 ± 3.47 55.80 ± 3.58 0.363
D28 57.73 ± 3.74 59.20 ± 3.43 0.360
Length Gain 3.37 ± 2.60 3.40 ± 0.84 0.967
Feeding
No. of feeding (per day) 6.36 ± 0.50 7.10 ± 0.57 0.005
Acceptance (Yes/No) Yes Yes —
Stool
Number (per day) 3.18 ± 0.40 2.50 ± 0.71 0.051
Consistency Normal 72.7% Normal 60% 0.659
Soft 27.32% Soft 40%N.M. Lugonja et al.
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groups during the study. Stool frequency and consistency,
and side effects (flatus and regurgitations) were similar
between the groups.
Gut microbiota
Modifications in the levels of microbial colonization
between the beginning D0, D14 and the end of the supple-
mentation for both groups are compared in Table 2. The
bacterial counts are expressed as means ± SD 108 CFU/g
feces.
At D0 and D14, there were no significant differences in
bifidobacteria counts in the stools of FF group and the BMF
control group. By D28, however, the bifidobacterial levels in
the stools from the FF infants was significantly higher than
in the BMF infants (p28 = 0.008). During the study, the
bifidobacterial counts increased statistically significantly in
both groups, but the dynamics of the change in the F1 group
differed between groups: the mean bifidobacteria level in the
stools from the FF infants continually rose, from 11.42 (D0),
through 30.26 (D14) to 89.45 (D28) 108 CFU/g feces, while
in the BMF group, the levels increased at the beginning of
the study (from 8.83 at D0 to 17.56 by D14) but then
remained until D28 (17.53 × 108 CFU/g feces).
The number of lactobacilli, as intestinal probiotics,
increased in both the FF and BMF infants, without statisti-
cally significant differences in the numbers or dynamic of
change during the study. Simultaneously with the increase in
bifidobacterial and lactobacilli populations, decreases in
the total aerobes, anaerobes and yeasts and fungi levels were
observed. During the study, the numbers of total aerobes and
yeasts and fungi continually decreased in the stools of the FF
infants, without statistically significant differences between
the groups at the end of the study. The anaerobes decreased
in both groups during the study, with significant differences
with time but without significantly different rates of change.
Biochemical parameters
The type of feed affected the pH value and TOA content of
the stools obtained from the infants during the study
(Table 3). The FF and BMF groups were statistically
different in the dynamics of the change pH in the groups
(p<0.05). Stool pH continually decreased in the FF group
but in the BMF group, the pH decreased from D0 to D14 of
study and thereafter slightly increased to the end of the
Table 2. Level of infant’s gut colonization in the FF and BMF groups (given as mean ± SD)
*The p value represents the significance level of the difference in the change between the groups during the study, determined by the inde-
pendent-sample t test.
**F1 and F1 group—given as the internal group factor (within subject factors—F1) and as the factor of differences between the groups
(between subject factors—F1 group).
Type of feeding
CFU × 108/g of feces in the following group
p* F1** F1 group** Infant formula with added 
inulin and FOS (FF)
Breastfeeding (BMF)
Bifidobacterium 0.006 0.024
D0 11.42 ± 10.72 8.83 ± 9.62 0.567
D14 30.26 ± 21.82 17.56 ± 32.86 0.305
D28 89.45 ± 73.62 17.53 ± 21.47 0.008
Lactobacillus 0.134 0.349
D0 17.22 ± 9.67 17.47 ± 16.31 0.965
D14 64.64 ± 77.38 26.77 ± 41.11 0.184
D28 137.99 ± 227.78 33.48 ± 47.42 0.172
Aerobes 0.135 0.107
D0 86.11 ± 117.96 42.86 ± 97.89 0.375
D14 32.80 ± 21.34 19.72 ± 18.72 0.154
D28 14.46 ± 19.92 22.30 ± 29.21 0.477
Anaerobes 0.040 0.987
D0 98.37 ± 80.72 117.04 ± 184.36 0.763
D14 75.89 ± 101.44 83.60 ± 162.06 0.896
D28 26.31 ± 25.09 42.94 ± 7.09 0.160
Yeasts and Fungi 0.296 0.075
D0 25.78 ± 35.20 8.68 ± 14.03 0.168
D14 13.22 ± 9.34 3.67 ± 3.73 0.007
D28 5.06 ± 5.68 9.32 ± 16.09 0.419Comparative Bifidogenic Effect of an Infant Formula
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study. The TOA in the stools from both groups, calculated as
lactic acid, increased during time but at the end of the study
was higher in the FF than in the BMF infants. The influence
of the diet on the change in fecal pH and TOA was statisti-
cally significant (p<0.05).
The feed type significantly influenced the stool consistency
scores, computed as % water content in the stool sample.
For the FF infants, the consistency changed to softer stools,
close to the scores found for the BMF infants. This confirms
the anthropometric results for stool consistency, where 72%
of stools from the FF infants were normal consistency vs
60% of those from the BMF infants.
In vitro test
Microbiological and biochemical indicators were deter-
mined at the beginning and at the end of the in vitro test
(Table 4). Microbiological parameters for both substrates
(IF and MBM) were identical at the beginning of the test
(TNB, 6.27 × 108 CFU/ml and DBM, 0.029 g/100 ml). In the
native preparation, the bifidobacterial cells were extremely
small and of irregular, characteristically elongated shape.
After 48 h, the TNB in both substrates had increased and
was higher in the IF (1.12 × 1010/ml) than in MBM group
(4.9 × 109/ml). As was to be expected, the most suitable
substrate for the production of biomass was MBM (0.262
g/100 ml) compared with IF (0.234 g/100 ml), after 48 h of
bifidogenesis. The bifidogenic index (BI) is the ratio of
bifidobacteria dry biomass obtained at the end of the test
with infant formula divided by that obtained with breast
milk in the same series of the experiment multiplied by
Table 3. Biochemical data in stools from the groups of the infants enrolled in the study (given as mean ± SD)
*The p value represents the significance level of the difference in the change between the groups during the study.
**F1 and F1 group—given as the internal group factor (within subject factors—F1) and as the factor of differences between the groups
(between subject factors—F1 group).
TOA—Total organic acids, calculated as lactic acid (g/100 ml).
Type of feeding
Study group
p* F1** F1 group** Infant formula with added 
inulin and FOS (FF)
Breastfeeding (BMF)
pH 0.001 0.001
D0 7.03 ± 0.83 6.11 ± 1.32 0.070
D14 6.52 ± 0.44 5.95 ± 1.15 0.146
D28 5.90 ± 0.35 6.01 ± 1.39 0.798
TOA 0.003 0.027
D0 0.0156 ± 0.0226 0.0221 ± 0.0295 0.577
D14 0.0199 ± 0.0176 0.0288 ± 0.0253 0.356
D28 0.0401 ± 0.0218 0.0288 ± 0.0236 0.151
Water content (%) 0.038 0.140
D0 73.87 ± 6.52 77.60 ± 8.74 0.280
D14 76.49 ± 4.62 69.62 ± 19.68 0.274
D28 77.93 ± 4.70 81.18 ± 5.27 0.151
Table 4. Microbiological and biochemical indicators of in vitro
bifidogenesis (given as mean ± SD)
TNB0—Total number of bifidobacteria expressed as CFU × 108/ml
(at the beginning).
TNB48—Total number of bifidobacteria expressed as CFU × 1010/ml
(at the end).
DBM—Dry biomass (g/100 ml).
pHa after pancreatic enzymes-simulated digestion.
pH0 at the beginning of the experiment.
pH48 at the end of the test.
TOA—Total organic acids, calculated as lactic acid (g/100 ml).
MRAL—Mole ratio of acetic and lactic acid.
BI—Bifidogenic index.
Substrate
Infant formula with added 
inulin and FOS (IF)
Mature breast milk 
(MBM)
TNB
TNB0 6.27 ± 0.59 6.27 ± 0.59
TNB48 1.12 ± 0.22 0.49 ± 0.38
DBM
DBM0 0.029 ± 0.012 0.029 ± 0.012
DBM48 0.234 ± 0.044 0.262 ± 0.036
pH
pHa 6.73 7.04
pH0 5.40 5.79
pH48 4.32 4.94
TOA 0.145 0.067
MRAL 3.06 : 1.86 2.95 : 1.90
BI (%) 0.89 1N.M. Lugonja et al.
J. Clin. Biochem. Nutr.
214
hundred (i.e., expressed as a percentage); it is a discrimina-
tory criterion for an estimation of the bifidogenic effects.
The BI values obtained in this study showed that IF had a
high BI value (0.89).
At the beginning of the in vitro test, the TOA values were
0.005 g/100 ml in both substrates. At the end of the process,
the concentration of the bacterially generated organic acids
was higher in the IF (0.145 g/100 ml) than in the reference
substrate, MBM (0.067 g/100 ml), while the substrate pH
values were 4.32 and 4.94 for IF and MBM, respectively.
The mole ratio of the produced acetic and lactic acids in
both tested substrates was very close to 3:2, which is a
physiological and biochemical characteristic of the genus
Bifidobacterium [31].
Discussion
Studies published to date have shown that interactions
exist between infant’s dietary types, intestinal flora and the
development of the gastrointestinal tract and the immune
system [20]. As a result of these complex interactions,
dietary factors, including prebiotics, can improve the growth
and function of intestinal bacteria [1]. This study showed
both clinically and in vitro that inulin and FOS, as prebiotic
additives in infant formula, can influence bifidogenesis in
the infant. From the results of the in vitro test and clinical
investigation, which studied bifidogenesis in unweaned
infants younger than 6 months fed on an infant formula
containing additional inulin and FOS or breastfed, the
following can be concluded: The total numbers of bifido-
bacteria observed in the clinical study were greater in the
stools from FF than in the stools from BMF infants; bifido-
bacteria were also observed in an in vitro test, the IF
substrate contained more bifidobacteria than MBM—the
gold standard. The dry biomass of bifidobacteria, i.e., the
bifidogenic effect, which is one of the most important
parameters for assessing the biological value and overall
quality of infant formula, is the best indicator for comparing
these products. The bifidogenic index, established in the in
vitro test as a discriminatory criterion for describing the
bifidogenic effect, showed the relationship between dry
biomass in the examined sample compared with that of
breast milk, and clearly categorized the tested product. The
examined infant formula stimulated the growth of bifido-
bacteria to a high degree; in fact, to a level very similar to
that achieved by human breast milk. A healthy microflora is
essential for the general development of unweaned infants,
since it plays an important role in the normal diet and
metabolism. The clinical study showed that the infant
formula supplemented with inulin and FOS stimulated the
growth of bifidobacteria in the intestine, resulting in a
reduced pH and increased content of total organic acids;
this was also found in the in vitro test. The increase of the
TOA value in combination with the lowered pH value
influences the growth of other groups of bacteria, as well as
yeasts and fungi in the colon, since their growth is inhibited
by a combination of weak organic acids and low pH, as well
as by specific bacteriocins secreted by lactic acid bacteria
[32, 33]. The changes induced by the prebiotics inulin and
FOS contribute to the intestinal flora and their metabolic
activity in unweaned infants fed with these compounds in a
manner very similar to that of infants exclusively nursed on
breast milk.
The biochemical and microbiological indicators in the in
vitro test resulted from changes in the substrates, which were
exclusively caused by the action of bifidobacteria, and
stimulation of their proliferation by the prebiotics in the
infant formula and in breast milk.
The molar ratio of acetic to lactic acids in both in vitro-
tested milks was close to 3:2, which is a physiological and
biochemical characteristic of the genus Bifidobacterium
(with no production of CO2) [31]. This result additionally
confirms, besides the RAPID ID 32A® system for identifica-
tion of anaerobes, that the isolated accumulated mixed
culture used to inoculate the in vitro test was comprised only
of bifidobacterial species and that changes in the substrates
were the result of their actions and bifidogenesis. This,
therefore, is a control indicator that the changes really were
the consequence of the bifidogenesis effect in the substrates.
The clinical test of the infant formula containing addi-
tional inulin and FOS showed that a diet with this formula
had no statistically significant effects on the anthropometric
factors of growth and development of the infants (length,
weight) compared with the control group of breastfed
infants. In addition, the development of the intestinal flora,
which (especially the bifidobacteria) is less developed in
children fed exclusively on adapted formula [34], was at
the level of breast milk with the examined formula. The
numbers of microorganisms found in the FF group were
statistically similar to those found in the control group,
except for bifidobacteria, which were present in signifi-
cantly greater numbers. It is important that the number of
bifidobacteria in infants feeding on formula is as high as
possible, since these organisms protect the infants from
allergies and infections [4, 5]. The number and consistency
of stools did not statistically differ between the two groups
of infants, which is important since FF infants often pass
firmer stools than breastfed infants [35].
Based on the results obtained during the clinical and in
vitro tests conducted during this study, it can be concluded
that the infant formula containing additional prebiotics
(inulin and FOS) and mature breast milk have similar
bifidogenic effects. Infant formula containing additional
inulin and FOS obtained from natural sources is safe for
use, it favorably influences the growth and development of
infants, is well accepted, and favorably influences theComparative Bifidogenic Effect of an Infant Formula
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development of good microflora and stool consistency.
The artificial system developed to estimate the bifidogenic
effect  in vitro can be used to rapidly and objectively
determine the bifidogenic effect of infant formula compared
to mature breast milk as a reference substrate. Under
controlled conditions, the in vitro test is a rapid method
for the determination of the bifidogenic effect, as it takes
just 48 h. Microbiological and biochemical indicators deter-
mined in the test are suitable for following the process of
in vitro bifidogenesis. The dry biomass of bifidobacteria is
the best indicator, the use of which enables the bifidogenic
effects of infant formula to be compared, and it is one of
the most important parameters of the biological value and
overall quality of these foods. The Bifidogenic Index
conducted as a discriminatory criterion for determining the
bifidogenic effect, clearly categorizes and ranks the tested
products.
The  in vitro test described in this study allows the
bifidogenic effect of infant formula to be rapidly and objec-
tively confirmed in a controlled manner, in contrast to a
clinical study, which lasts several months and depends on a
large number of factors, many of which cannot be influenced
or controlled. However, this in vitro test cannot reproduce
the natural conditions in the gut of unweaned infants.
Therefore, it is also necessary to clinically test new formula,
and determine their acceptability and biological value. For
these reasons, this in vitro test should be used in the first
phase for confirmation of the bifidogenic effect. It can also
be employed as a discriminatory test to compare and rank
different infant formula.
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